APLLTD Intraday Analysis...

APLLTD Share Price

Open 525.00 Change Price %
High 525.45 1 Day 0.45 0.09
Low 512.00 1 Week 3.25 0.63
Close 516.10 1 Month 15.80 3.16
Volume 31677 1 Year -93.50 -15.34
52 Week High 673.70
52 Week Low 469.85
APLLTD Important Levels
Resistance 2 528.57
Resistance 1 523.43
Pivot 517.85
Support 1 508.77
Support 2 503.63
NSE INDIA Most Active Stocks
HDFCLIFE 344.60 18.83%
RCOM 12.10 3.42%
HDIL 63.95 7.03%
JPASSOCIAT 18.65 -0.27%
RTNPOWER 7.60 5.56%
BANKBARODA 183.55 0.41%
SUZLON 13.70 1.86%
PNB 190.80 0.63%
SBIN 337.50 1.23%
DLF 223.85 7.26%
More..
NSE INDIA Top Gainers Stocks
SUNDARAM 4.20 20.00%
NAGAROIL 3.90 20.00%
PKTEA 229.90 19.99%
PROVOGE 5.75 19.79%
HDFCLIFE 344.60 18.83%
ZUARIGLOB 227.70 14.42%
RENUKA 17.55 13.96%
MAHASTEEL 69.10 13.84%
BALAMINES 613.10 13.60%
PATINTLOG 87.90 12.84%
More..
NSE INDIA Top Losers Stocks
VIPCLOTHNG 54.30 -14.01%
SAMTEL 0.45 -10.00%
LSIL 2.05 -8.89%
WSI 6.40 -7.91%
NBIFIN 2752.40 -6.70%
PRADIP 2.20 -6.38%
MOHITIND 47.55 -6.12%
CUBEXTUB 30.40 -5.00%
PINCON 38.00 -5.00%
STCINDIA 207.20 -5.00%
More..

Alembic Pharmaceuticals Limited (NSE: APLLTD)

APLLTD Technical Analysis 2
As on 17th Nov 2017 APLLTD Share Price closed @ 516.10 and we RECOMMEND Sell for LONG-TERM with Stoploss of 555.96 & Strong Buy for SHORT-TERM with Stoploss of 502.89 we also expect STOCK to react on Following IMPORTANT LEVELS.
APLLTD Target for November
1st Target up-side 525.24
2nd Target up-side 539.61
3rd Target up-side 553.97
1st Target down-side 484.26
2nd Target down-side 469.89
3rd Target down-side 455.53
APLLTD Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 59.10 Sideways
MFI (14) MFI is 52.06 Sideways
CCI (20) CCI is 81.16 Sideways
WILLIAM %R (14) William %R is -51.77 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 508.41
10 Day Avg Volume Traded -81.66 % Less then 10 Day Average Volume
APLLTD Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
APLLTD Address
APLLTD
N/A
APLLTD Latest News
Alembic Pharma - Q3 results on Feb 04, 2015   Moneycontrol.com   - 23rd Jan 15
Alembic Pharma buying 49% stake in Algerian drugmaker Adwiya Mami   VC Circle   - 27th Oct 14
Alembic Pharma, Hester Biosciences net profit jumps 25%, 66% respectively   Economic Times   - 21st Oct 14
Alembic Pharma Q2 net up 54%   Business Standard   - 25th Oct 13
Alembic Pharma's net profit 27 pc up; to abandon low margin API & formulation   Economic Times   - 02nd May 13
Alembic Pharma to focus on regulated markets   Business Standard   - 21st Jan 13
Alembic Pharma will add more specialty product, Q2 net profit up 12%   Economic Times   - 19th Oct 12
Alembic Pharma - Fire at API 1 plant at Panelav, Gujarat   Moneycontrol.com   - 27th Aug 12
Alembic Pharma   Moneycontrol.com   - 20th Sep 11
Alembic Pharma sales up 34%, plans Brazil foray   Economic Times   - 27th Jul 11
Interactive Technical Analysis Chart Alembic Pharmaceuticals Limited ( APLLTD NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Alembic Pharmaceuticals Limited
APLLTD Business Profile
Alembic Pharma is in the Pharmaceuticals sector. It is established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara. The current market capitalisation stands at Rs 3,760.89 crore.The company has reported a consolidated sales of Rs 484.28 crore and a Net Profit of Rs 61.64 crore for the quarter ended Sep 2013. The company management includes Chirayu R Amin - Chairman & Managing Director, K G Ramanathan - Director, Paresh Saraiya - Director, Pranav N Parikh - Director, Milin Mehta - Director, Pranav Amin - President & Director, Shaunak Amin - President & Director, R K Baheti - Dir-President & Com.Secretary. It is listed on the BSE with a BSE Code of 533573 and the NSE with an NSE Code of APLLTD. Its Head office is at Alembic Road , Vadodra,Gujarat - 390003.